Scadenza: 6 May 2021
Topic:
Project results are expected to contribute to all the following expected outcomes:
- comprehensive catalogue of research infrastructure services relevant to tackle infectious diseases epidemics is available, including services supporting pertinent social sciences research;
- fast assembly and provision of innovative, customised and efficient research infrastructure services to support research linked to detecting, assessing and combatting newly emerging SARS-CoV-2 variants;
- challenge driven integration of research infrastructures to better support research addressing infectious diseases and face epidemics, including for use by epidemics risk assessment and risk management bodies (such as the European Centre for Disease prevention and Control (ECDC), the World Health Organisation (WHO), the World Organisation of Animal Health (OIE) and national epidemics management bodies);
- rapid response to epidemics outbreaks through research infrastructure services underpinning and supporting research aiming to understand causes and development of the epidemic;
- development of novel/adapted epidemics intervention tools and measures enabled by relevant research infrastructure (RI) services;
- availability of research data emerging from access provision activities for re-use on common data platforms and registries, according to FAIR principles and compliant with legal provisions under the General Data Protection Regulation (GDPR).
Proposals under this action, will integrate research infrastructure services to form a comprehensive and inclusive portfolio to support research in response to infectious disease epidemics or underpinning respective forefront research in the field. As a first immediate challenge, the delivered services should support research targeting newly emerging SARS-Cov-2 variants and addressing the on-going COVID-19 pandemic.
Programma:
Horizon Europe Framework Programme (HORIZON)
Type of action
HORIZON-RIA HORIZON Research and Innovation Actions
Ente finanziatore:
EU
Budget complessivo:
21.000.000 €
Who can participate:
Any legal entity, regardless of its place of establishment, including legal entities from nonassociated third countries or international organisations (including international European research organisations) is eligible to participate
Partnership: Mandatory
Status:
Closed
Quota finanziabile:
100%
Topic:
Project results are expected to contribute to all the following expected outcomes:
- comprehensive catalogue of research infrastructure services relevant to tackle infectious diseases epidemics is available, including services supporting pertinent social sciences research;
- fast assembly and provision of innovative, customised and efficient research infrastructure services to support research linked to detecting, assessing and combatting newly emerging SARS-CoV-2 variants;
- challenge driven integration of research infrastructures to better support research addressing infectious diseases and face epidemics, including for use by epidemics risk assessment and risk management bodies (such as the European Centre for Disease prevention and Control (ECDC), the World Health Organisation (WHO), the World Organisation of Animal Health (OIE) and national epidemics management bodies);
- rapid response to epidemics outbreaks through research infrastructure services underpinning and supporting research aiming to understand causes and development of the epidemic;
- development of novel/adapted epidemics intervention tools and measures enabled by relevant research infrastructure (RI) services;
- availability of research data emerging from access provision activities for re-use on common data platforms and registries, according to FAIR principles and compliant with legal provisions under the General Data Protection Regulation (GDPR).
Proposals under this action, will integrate research infrastructure services to form a comprehensive and inclusive portfolio to support research in response to infectious disease epidemics or underpinning respective forefront research in the field. As a first immediate challenge, the delivered services should support research targeting newly emerging SARS-Cov-2 variants and addressing the on-going COVID-19 pandemic.
Who can participate:
Any legal entity, regardless of its place of establishment, including legal entities from nonassociated third countries or international organisations (including international European research organisations) is eligible to participate
Programme:
Horizon Europe Framework Programme (HORIZON)
Type of action
HORIZON-RIA HORIZON Research and Innovation Actions
Consortium: Required
Status: Open
Total budget:
21.000.000 €
Funding rate:
100%
